Cannon Global Investment Management, LLC Aclaris Therapeutics, Inc. Transaction History
Cannon Global Investment Management, LLC
- $49.7 Million
- Q1 2025
A detailed history of Cannon Global Investment Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Cannon Global Investment Management, LLC holds 37,400 shares of ACRS stock, worth $49,742. This represents 0.11% of its overall portfolio holdings.
Number of Shares
37,400Holding current value
$49,742% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
106Shares Held
87.8MCall Options Held
293KPut Options Held
124K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$19 Million21.95% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$12.8 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$11.8 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$8.25 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$6.21 Million0.19% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $88.7M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...